nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—NTSR2—spinal cord—acquired immunodeficiency syndrome	0.0411	0.261	CbGeAlD
Levocabastine—NTSR2—nervous system—acquired immunodeficiency syndrome	0.0346	0.22	CbGeAlD
Levocabastine—NTSR2—central nervous system—acquired immunodeficiency syndrome	0.0333	0.212	CbGeAlD
Levocabastine—NTSR2—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0326	0.0791	CbGpPWpGaD
Levocabastine—NTSR2—brain—acquired immunodeficiency syndrome	0.0264	0.168	CbGeAlD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.0253	0.0614	CbGpPWpGaD
Levocabastine—NTSR2—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0182	0.0442	CbGpPWpGaD
Levocabastine—NTSR2—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.0171	0.0415	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.017	0.0412	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.0153	0.0372	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.0139	0.0336	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0129	0.0314	CbGpPWpGaD
Levocabastine—NTSR2—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.0117	0.0285	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.0103	0.0249	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.00947	0.023	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0093	0.0226	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00856	0.0208	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.00805	0.0195	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.00805	0.0195	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00783	0.019	CbGpPWpGaD
Levocabastine—Eye pain—Indinavir—acquired immunodeficiency syndrome	0.00738	0.0171	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00708	0.0172	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.0067	0.0163	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00663	0.0161	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00635	0.0154	CbGpPWpGaD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.0063	0.0153	CbGpPWpGaD
Levocabastine—Eye pain—Ritonavir—acquired immunodeficiency syndrome	0.00617	0.0143	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00613	0.0149	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00574	0.0139	CbGpPWpGaD
Levocabastine—Pharyngitis—Nelfinavir—acquired immunodeficiency syndrome	0.00567	0.0132	CcSEcCtD
Levocabastine—Pharyngitis—Stavudine—acquired immunodeficiency syndrome	0.00566	0.0131	CcSEcCtD
Levocabastine—Visual disturbance—Saquinavir—acquired immunodeficiency syndrome	0.00566	0.0131	CcSEcCtD
Levocabastine—Pharyngitis—Abacavir—acquired immunodeficiency syndrome	0.00557	0.0129	CcSEcCtD
Levocabastine—NTSR2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.00552	0.0134	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.0054	0.0131	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.0054	0.0131	CbGpPWpGaD
Levocabastine—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00514	0.0119	CcSEcCtD
Levocabastine—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00498	0.0116	CcSEcCtD
Levocabastine—Pharyngitis—Zidovudine—acquired immunodeficiency syndrome	0.00492	0.0114	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00484	0.0117	CbGpPWpGaD
Levocabastine—Dry mouth—Didanosine—acquired immunodeficiency syndrome	0.00476	0.0111	CcSEcCtD
Levocabastine—Pharyngitis—Indinavir—acquired immunodeficiency syndrome	0.00457	0.0106	CcSEcCtD
Levocabastine—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.00441	0.0102	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00437	0.0106	CbGpPWpGaD
Levocabastine—Cough—Stavudine—acquired immunodeficiency syndrome	0.00433	0.0101	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.00432	0.0105	CbGpPWpGaD
Levocabastine—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00431	0.01	CcSEcCtD
Levocabastine—Cough—Abacavir—acquired immunodeficiency syndrome	0.00427	0.00991	CcSEcCtD
Levocabastine—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.0042	0.00974	CcSEcCtD
Levocabastine—Pharyngitis—Delavirdine—acquired immunodeficiency syndrome	0.00413	0.0096	CcSEcCtD
Levocabastine—Dry mouth—Stavudine—acquired immunodeficiency syndrome	0.00413	0.00959	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00411	0.00998	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00411	0.00998	CbGpPWpGaD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00411	0.00997	CbGpPWpGaD
Levocabastine—HRH1—digestive system—acquired immunodeficiency syndrome	0.00404	0.0257	CbGeAlD
Levocabastine—NTSR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00402	0.00975	CbGpPWpGaD
Levocabastine—Pain—Didanosine—acquired immunodeficiency syndrome	0.00399	0.00926	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00392	0.00951	CbGpPWpGaD
Levocabastine—Pharyngitis—Ritonavir—acquired immunodeficiency syndrome	0.00382	0.00888	CcSEcCtD
Levocabastine—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00379	0.0088	CcSEcCtD
Levocabastine—Cough—Zidovudine—acquired immunodeficiency syndrome	0.00376	0.00874	CcSEcCtD
Levocabastine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.00373	0.00866	CcSEcCtD
Levocabastine—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.00371	0.00862	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.0037	0.00898	CbGpPWpGaD
Levocabastine—Pharyngitis—Saquinavir—acquired immunodeficiency syndrome	0.00368	0.00854	CcSEcCtD
Levocabastine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00367	0.00853	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00363	0.00882	CbGpPWpGaD
Levocabastine—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00363	0.00842	CcSEcCtD
Levocabastine—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00362	0.00841	CcSEcCtD
Levocabastine—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00362	0.0084	CcSEcCtD
Levocabastine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.00361	0.00839	CcSEcCtD
Levocabastine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.0036	0.00836	CcSEcCtD
Levocabastine—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00359	0.00833	CcSEcCtD
Levocabastine—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.00357	0.0083	CcSEcCtD
Levocabastine—HRH1—vagina—acquired immunodeficiency syndrome	0.00357	0.0227	CbGeAlD
Levocabastine—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.00356	0.00826	CcSEcCtD
Levocabastine—Pharyngitis—Lamivudine—acquired immunodeficiency syndrome	0.00351	0.00815	CcSEcCtD
Levocabastine—Cough—Indinavir—acquired immunodeficiency syndrome	0.0035	0.00813	CcSEcCtD
Levocabastine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00349	0.00811	CcSEcCtD
Levocabastine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00347	0.00807	CcSEcCtD
Levocabastine—Pain—Stavudine—acquired immunodeficiency syndrome	0.00346	0.00804	CcSEcCtD
Levocabastine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00344	0.00799	CcSEcCtD
Levocabastine—Pain—Abacavir—acquired immunodeficiency syndrome	0.00341	0.00792	CcSEcCtD
Levocabastine—HRH1—lung—acquired immunodeficiency syndrome	0.00338	0.0215	CbGeAlD
Levocabastine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00335	0.00777	CcSEcCtD
Levocabastine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.00334	0.00776	CcSEcCtD
Levocabastine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00331	0.00768	CcSEcCtD
Levocabastine—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00323	0.00749	CcSEcCtD
Levocabastine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00323	0.00749	CcSEcCtD
Levocabastine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00322	0.00749	CcSEcCtD
Levocabastine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00321	0.00744	CcSEcCtD
Levocabastine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.00316	0.00735	CcSEcCtD
Levocabastine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.00316	0.00733	CcSEcCtD
Levocabastine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00314	0.00729	CcSEcCtD
Levocabastine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.00313	0.00727	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00313	0.00759	CbGpPWpGaD
Levocabastine—HRH1—nervous system—acquired immunodeficiency syndrome	0.00313	0.0199	CbGeAlD
Levocabastine—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00308	0.00715	CcSEcCtD
Levocabastine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00304	0.00706	CcSEcCtD
Levocabastine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00303	0.00705	CcSEcCtD
Levocabastine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00302	0.00701	CcSEcCtD
Levocabastine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.00301	0.0191	CbGeAlD
Levocabastine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00301	0.00699	CcSEcCtD
Levocabastine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00301	0.00699	CcSEcCtD
Levocabastine—Rash—Didanosine—acquired immunodeficiency syndrome	0.00294	0.00683	CcSEcCtD
Levocabastine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00294	0.00682	CcSEcCtD
Levocabastine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00293	0.00679	CcSEcCtD
Levocabastine—Headache—Didanosine—acquired immunodeficiency syndrome	0.00292	0.00679	CcSEcCtD
Levocabastine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00292	0.00678	CcSEcCtD
Levocabastine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00291	0.00677	CcSEcCtD
Levocabastine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.00291	0.00676	CcSEcCtD
Levocabastine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00291	0.00675	CcSEcCtD
Levocabastine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00286	0.00665	CcSEcCtD
Levocabastine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00282	0.00655	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00282	0.00684	CbGpPWpGaD
Levocabastine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00282	0.00654	CcSEcCtD
Levocabastine—Pain—Indinavir—acquired immunodeficiency syndrome	0.0028	0.0065	CcSEcCtD
Levocabastine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00279	0.00648	CcSEcCtD
Levocabastine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00277	0.00643	CcSEcCtD
Levocabastine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00276	0.0064	CcSEcCtD
Levocabastine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00275	0.00639	CcSEcCtD
Levocabastine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00269	0.00624	CcSEcCtD
Levocabastine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00269	0.00624	CcSEcCtD
Levocabastine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00267	0.00619	CcSEcCtD
Levocabastine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00264	0.00614	CcSEcCtD
Levocabastine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00264	0.00614	CcSEcCtD
Levocabastine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00264	0.00614	CcSEcCtD
Levocabastine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00264	0.00613	CcSEcCtD
Levocabastine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00263	0.00611	CcSEcCtD
Levocabastine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00263	0.0061	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00257	0.00625	CbGpPWpGaD
Levocabastine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00256	0.00595	CcSEcCtD
Levocabastine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00256	0.00595	CcSEcCtD
Levocabastine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00256	0.00594	CcSEcCtD
Levocabastine—Rash—Stavudine—acquired immunodeficiency syndrome	0.00255	0.00593	CcSEcCtD
Levocabastine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00255	0.00592	CcSEcCtD
Levocabastine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00255	0.00592	CcSEcCtD
Levocabastine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00254	0.00591	CcSEcCtD
Levocabastine—Headache—Stavudine—acquired immunodeficiency syndrome	0.00254	0.00589	CcSEcCtD
Levocabastine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00253	0.00588	CcSEcCtD
Levocabastine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00253	0.00586	CcSEcCtD
Levocabastine—Rash—Abacavir—acquired immunodeficiency syndrome	0.00252	0.00584	CcSEcCtD
Levocabastine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00251	0.00584	CcSEcCtD
Levocabastine—Headache—Abacavir—acquired immunodeficiency syndrome	0.0025	0.0058	CcSEcCtD
Levocabastine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00249	0.00579	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00248	0.00602	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00247	0.006	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—IL4—acquired immunodeficiency syndrome	0.00246	0.00598	CbGpPWpGaD
Levocabastine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00244	0.00567	CcSEcCtD
Levocabastine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00243	0.00565	CcSEcCtD
Levocabastine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00241	0.0056	CcSEcCtD
Levocabastine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00241	0.00559	CcSEcCtD
Levocabastine—HRH1—brain—acquired immunodeficiency syndrome	0.00239	0.0152	CbGeAlD
Levocabastine—NTSR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00237	0.00576	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00237	0.00576	CbGpPWpGaD
Levocabastine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00237	0.0055	CcSEcCtD
Levocabastine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00236	0.00548	CcSEcCtD
Levocabastine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00235	0.00545	CcSEcCtD
Levocabastine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00235	0.00545	CcSEcCtD
Levocabastine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.00234	0.00544	CcSEcCtD
Levocabastine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00234	0.00543	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00232	0.00564	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00232	0.00564	CbGpPWpGaD
Levocabastine—HRH1—lymph node—acquired immunodeficiency syndrome	0.00231	0.0147	CbGeAlD
Levocabastine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00227	0.00527	CcSEcCtD
Levocabastine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00225	0.00523	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00224	0.00545	CbGpPWpGaD
Levocabastine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00224	0.0052	CcSEcCtD
Levocabastine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00223	0.00519	CcSEcCtD
Levocabastine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00222	0.00515	CcSEcCtD
Levocabastine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00222	0.00515	CcSEcCtD
Levocabastine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00222	0.00515	CcSEcCtD
Levocabastine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00221	0.00512	CcSEcCtD
Levocabastine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00217	0.00503	CcSEcCtD
Levocabastine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00215	0.00499	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00215	0.00521	CbGpPWpGaD
Levocabastine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00212	0.00493	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00211	0.00512	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00211	0.00512	CbGpPWpGaD
Levocabastine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00209	0.00486	CcSEcCtD
Levocabastine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00206	0.00479	CcSEcCtD
Levocabastine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00206	0.00479	CcSEcCtD
Levocabastine—Headache—Indinavir—acquired immunodeficiency syndrome	0.00205	0.00476	CcSEcCtD
Levocabastine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00196	0.00456	CcSEcCtD
Levocabastine—HRH1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00196	0.00476	CbGpPWpGaD
Levocabastine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00195	0.00453	CcSEcCtD
Levocabastine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00195	0.00452	CcSEcCtD
Levocabastine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00194	0.00452	CcSEcCtD
Levocabastine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00194	0.0045	CcSEcCtD
Levocabastine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00189	0.00439	CcSEcCtD
Levocabastine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00187	0.00433	CcSEcCtD
Levocabastine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00186	0.00433	CcSEcCtD
Levocabastine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00185	0.00431	CcSEcCtD
Levocabastine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00184	0.00427	CcSEcCtD
Levocabastine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.0018	0.00419	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00177	0.00429	CbGpPWpGaD
Levocabastine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00176	0.00408	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00174	0.00423	CbGpPWpGaD
Levocabastine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00173	0.00401	CcSEcCtD
Levocabastine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.004	CcSEcCtD
Levocabastine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00171	0.00398	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.0017	0.00412	CbGpPWpGaD
Levocabastine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00386	CcSEcCtD
Levocabastine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00385	CcSEcCtD
Levocabastine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00165	0.00383	CcSEcCtD
Levocabastine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.00377	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00161	0.0039	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00159	0.00387	CbGpPWpGaD
Levocabastine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00368	CcSEcCtD
Levocabastine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00368	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00158	0.00384	CbGpPWpGaD
Levocabastine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00157	0.00366	CcSEcCtD
Levocabastine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00156	0.00363	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00156	0.00378	CbGpPWpGaD
Levocabastine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00149	0.00347	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00147	0.00356	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.00145	0.00351	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00141	0.00342	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.00133	0.00322	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00125	0.00303	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00125	0.00303	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00119	0.00288	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00107	0.00261	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00102	0.00247	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00101	0.00244	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000963	0.00234	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000956	0.00232	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000948	0.0023	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000934	0.00227	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00092	0.00223	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000871	0.00211	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000855	0.00207	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000836	0.00203	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000819	0.00199	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000819	0.00199	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000734	0.00178	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000663	0.00161	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000655	0.00159	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000624	0.00151	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000624	0.00151	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000623	0.00151	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000609	0.00148	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000594	0.00144	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000561	0.00136	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000551	0.00134	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000494	0.0012	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000491	0.00119	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000475	0.00115	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000428	0.00104	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000376	0.000914	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000375	0.00091	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.00036	0.000874	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.00036	0.000874	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000353	0.000855	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000353	0.000855	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00034	0.000826	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000326	0.00079	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00032	0.000777	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00032	0.000777	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.00029	0.000704	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000268	0.000651	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000264	0.000641	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.000257	0.000625	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000244	0.000591	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000242	0.000586	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.00024	0.000582	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000222	0.00054	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000219	0.000532	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000201	0.000488	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000189	0.000459	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000189	0.000459	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000144	0.000349	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000142	0.000344	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.00014	0.000339	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.00013	0.000315	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000127	0.000308	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.49e-05	0.000182	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.45e-05	0.000181	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.4e-05	0.000107	CbGpPWpGaD
